Funding boost Enzymlogic recently secured a €2.2 million grant from the European Commission and the Spanish Innovation Agency (CDTI) to deploy KINETICfinder across pharma and biotech clients, signaling strong validation and potential for scaled collaborations.

Kinetic leadership Specialization in kinetic profiling and high-quality kinetic data positions Enzymlogic as a strategic partner for early drug discovery programs seeking speed, scale, and enhanced medicinal chemistry iteration.

Awards credibility Historical recognition, including Seal of Excellence from the European Commission and multiple innovative startup awards, enhances credibility with potential customers and grant-funded projects.

Global partnerships Proven track record of collaborations with worldwide organizations of all sizes indicates readiness to integrate with large pharma as well as academic or smaller biotech groups seeking outside-in expertise.

Small team agility With a lean team (2–10 employees) and specialized services, Enzymlogic offers personalized engagement and rapid onboarding for pilot projects, making it suitable for quick start engagements and flexible pricing discussions.